NOV 06, 2019 11:16 AM PST

Cone Snail Venom Became and Pain Therapeutics

WRITTEN BY: Nouran Amin

Ever heard of conotoxins? They are bioactive peptides present in the venom of the predatory marine cone snails that are well known for their effective envenomation strategy. The conotoxins help these snails to capture prey and defend themselves against predators.

The carnivorous sea slugs are known for their poisoning mechanism, which helps the animals catch and defend their prey such as fish or shells. (© Markus Muttenthaler)

"Cone snails can control their venom composition depending if they hunt or defend themselves," says Markus Muttenthaler from the Institute of Biological Chemistry at the University of Vienna. "For pain research, we are particularly interested in the venom of a defending cone snail, as its composition is aimed at causing pain and its individual components can be used to study pain pathways," the ERC Starting Grant awardee states.

They were used to study pain signaling and hold the potential to become a new class of drugs under the analgesics—because of these studies there are 10,000+ conotoxin’s that have been identified.

"Conotoxins have revolutionised pain research since their extraordinary potency and selectivity enables us to study the individual subtypes of ion channels, which was not possible before," explains Markus Muttenthaler.

There has been one contoxin that received FDA-approval (Prialt®) for treating severe chronic pain. That particular drug can be administered via the spinal cord where it blocks pain being transmitted though an ion channel subtype -- "it is 1,000 times more potent than morphine and triggers no symptoms of dependence, which is a big problem with opioid drugs," says Muttenthaler. "This would enable us to intercept the pain signal before it is transmitted into the central nervous system."

Now, current studies on conotoxins can target nerve endings outside the spinal cord for safer administration of the therapeutics. Findings of the study were published in the journal "Chemical Reviews” and advances venom drug discovery.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 28, 2022
Health & Medicine
Antidepressants Not Associated Improved Quality of Life
APR 28, 2022
Antidepressants Not Associated Improved Quality of Life
According to a recently published study in PLoS, antidepressants do not improve health-related quality of life (HRQoL) o ...
APR 28, 2022
Immunology
Lipid Supplement May Reduce Inflammation in MS
APR 28, 2022
Lipid Supplement May Reduce Inflammation in MS
Administration of an inflammation-mediating lipid has shown promise in reducing multiple sclerosis-related inflammation ...
MAY 07, 2022
Drug Discovery & Development
Ibuprofen and Blood Pressure Medication Linked to Kidney Damage
MAY 07, 2022
Ibuprofen and Blood Pressure Medication Linked to Kidney Damage
A combination of ibuprofen and certain blood pressure medications could lead to acute kidney injury. The corresponding s ...
JUN 14, 2022
Cancer
Maintaining Sample Temperature: Q&A From a Corning Scientist
JUN 14, 2022
Maintaining Sample Temperature: Q&A From a Corning Scientist
Generally speaking, bad things can happen when a cell sample temperature gets too hot or too cold. Temperature instabili ...
JUN 21, 2022
Cell & Molecular Biology
From sample collection straight to RT-qPCR
JUN 21, 2022
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
JUN 23, 2022
Cannabis Sciences
The Latest Research on Cannabis Social Equity Programs
JUN 23, 2022
The Latest Research on Cannabis Social Equity Programs
Cannabis social equity programs are designed to increase licensure and employment opportunities for lower income and BIP ...
Loading Comments...